2020 YAFO ACCESS CHINA Online Spring Partnering Day
COVID-19 has a profound impact on global economy, and the healthcare industry has received high attention from the whole society. YAFO Life Science along with our partners has successfully organized the largest online corporate access event between China and Western biopharma industry on May 15th and 22nd. We helped 35 overseas companies from 10 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
SPRING EVENT HIGHLIGHTS
- Presenting Companies: 35 companies from 10 countries
- Total audience: 1858 viewers for 35 presenting companies.
- Follow-up meeting: 500+ requests for asset presenting opportunities.
- Assets: 100+ assets looking for China or global partnering or funding.
For the Spring Event, we had 1858 viewers for the 35 presenting companies and 100+ assets looking for China or global partnering or funding. After conference, we have gathered over 500+ follow-up requests for the presented partnering and investment opportunities. YAFO Life Science team will continue to follow up with potential investors, and arrange one-on-one meetings.
SAVE THE DATE - July 31 (Live) & August 7 (Replay Day), 2020 SUMMER EVENT
Our next ACCESS CHINA Summer event will be held on July 31 and August 7. We expect about 50 company presentations.
Every interested company looking for licensing in/out or equity financing is welcome to join us at the event! You can register through:
If you would like to have a copy of asset list of presenting companies from ACCESS CHINA Spring Event, please register our Summer Event or send us a request email with your personal info including name, title, company name, and business email:
- China: Wendi Xiang +86-137-3368-5995 firstname.lastname@example.org
- Europe: Gian Dell Antonio +44 7425-307-383 email@example.com
ABOUT ACCESS CHINA : The most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. Access China creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
ABOUT YAFO Life Science : The investment banking division of YAFO Capital with a focus on global biopharma licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Asia. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China.
Presenting Companies, Organizers & Other Supports